update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
Published 1 year ago • 74 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:43
the importance of understanding cellular functionality to develop biological therapies for cll
-
1:48
do all patients require maintenance therapy following allosct?
-
8:57
outcomes of sct in t-all and t-lbl
-
2:03
the current landscape of treatment for bpdcn
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
38:41
2022 acc/aha guidelines for the diagnosis and management of aortic disease: what is new?
-
1:33
the feasibility of tki treatment discontinuation in patients with ph all
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline
-
1:43
the changing treatment landscape of pnh: novel agents and combinations
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:25
key changes in the hct survivorship guidelines
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
3:29
next steps in the development of inkts for the treatment of hematological malignancies
-
1:01
update on the cll treatment landscape
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting